Hypertension and Atrial Fibrillation: Insight From Basic to Translational Science Into the Mechanisms and Management

Area of Science:

• Cardiology
• Hypertension Research
• Electrophysiology

Background:

• Global epidemics of atrial fibrillation (AF) and hypertension (HTN) increasingly affect younger populations.
• Hypertension-induced cardiac changes, including ventricular hypertrophy and atrial dilation, are key contributors to AF pathophysiology.
• Atrial cardiomyopathy, characterized by structural and electrical remodeling, is a critical link between HTN and AF.

Purpose of the Study:

• To review basic and translational science data on how hypertension leads to atrial cardiomyopathy and AF.
• To explore potential clinical applications for preventing and treating AF in hypertensive individuals.

Main Methods:

• Review of existing scientific literature and data.
• Analysis of pathophysiological mechanisms linking hypertension to atrial changes.
• Discussion of clinical implications and therapeutic strategies.

Main Results:

• Hypertension triggers complex cardiac alterations, including cellular and structural changes in the atria.
• These changes result in atrial cardiomyopathy, a significant risk factor for developing AF.
• Dysregulation of ion channels, the renin-angiotensin-aldosterone system, and autonomic function are implicated.

Conclusions:

• Hypertension is a major driver of atrial cardiomyopathy and subsequent atrial fibrillation.
• Targeting hypertension-induced cardiac remodeling offers potential therapeutic avenues for AF prevention and treatment.
• Further research integrating basic science and clinical findings is crucial for effective management.